Literature DB >> 25385339

'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Aleksandar Videnovic1, Alpar S Lazar2, Roger A Barker2, Sebastiaan Overeem3.   

Abstract

Circadian rhythms are physiological and behavioural cycles generated by an endogenous biological clock, the suprachiasmatic nucleus. The circadian system influences the majority of physiological processes, including sleep-wake homeostasis. Impaired sleep and alertness are common symptoms of neurodegenerative disorders, and circadian dysfunction might exacerbate the disease process. The pathophysiology of sleep-wake disturbances in these disorders remains largely unknown, and is presumably multifactorial. Circadian rhythm dysfunction is often observed in patients with Alzheimer disease, in whom it has a major impact on quality of life and represents one of the most important factors leading to institutionalization of patients. Similarly, sleep and circadian problems represent common nonmotor features of Parkinson disease and Huntington disease. Clinical studies and experiments in animal models of neurodegenerative disorders have revealed the progressive nature of circadian dysfunction throughout the course of neurodegeneration, and suggest strategies for the restoration of circadian rhythmicity involving behavioural and pharmacological interventions that target the sleep-wake cycle. In this Review, we discuss the role of the circadian system in the regulation of the sleep-wake cycle, and outline the implications of disrupted circadian timekeeping in neurodegenerative diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25385339      PMCID: PMC4344830          DOI: 10.1038/nrneurol.2014.206

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  171 in total

1.  Circadian clock genes oscillate in human peripheral blood mononuclear cells.

Authors:  Diane B Boivin; Francine O James; Aibin Wu; Park F Cho-Park; Huabao Xiong; Zhong S Sun
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

2.  Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.

Authors:  Simon P Fisher; Sarah W Black; Michael D Schwartz; Alan J Wilk; Tsui-Ming Chen; Webster U Lincoln; Helen W Liu; Thomas S Kilduff; Stephen R Morairty
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

3.  Circadian rest-activity rhythm disturbances in Alzheimer's disease.

Authors:  E J van Someren; E E Hagebeuk; C Lijzenga; P Scheltens; S E de Rooij; C Jonker; A M Pot; M Mirmiran; D F Swaab
Journal:  Biol Psychiatry       Date:  1996-08-15       Impact factor: 13.382

4.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

5.  Dopaminergic regulation of cone retinomotor movement in isolated teleost retinas: I. Induction of cone contraction is mediated by D2 receptors.

Authors:  A Dearry; B Burnside
Journal:  J Neurochem       Date:  1986-04       Impact factor: 5.372

6.  The hypothalamus in Parkinson disease.

Authors:  J W Langston; L S Forno
Journal:  Ann Neurol       Date:  1978-02       Impact factor: 10.422

7.  Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.

Authors:  Nigel I Wood; Valentina Carta; Stefan Milde; Elizabeth A Skillings; Catherine J McAllister; Y L Mabel Ang; Alasdair Duguid; Nadeev Wijesuriya; Samira Mohd Afzal; Joe X Fernandes; T W Leong; A Jennifer Morton; Jennifer Morton
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

Review 8.  Sleep and Alzheimer disease pathology--a bidirectional relationship.

Authors:  Yo-El S Ju; Brendan P Lucey; David M Holtzman
Journal:  Nat Rev Neurol       Date:  2013-12-24       Impact factor: 42.937

9.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

Review 10.  Melatonin in Alzheimer's disease.

Authors:  Li Lin; Qiong-Xia Huang; Shu-Sheng Yang; Jiang Chu; Jian-Zhi Wang; Qing Tian
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

View more
  122 in total

Review 1.  Obesity, the deadly quartet and the contribution of the neglected daily organ rest - a new dimension of un-health and its prevention.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2015-08       Impact factor: 7.293

Review 2.  Are sleep disturbances preclinical markers of Parkinson's disease?

Authors:  Altair B dos Santos; Kristi A Kohlmeier; George E Barreto
Journal:  Neurochem Res       Date:  2014-11-30       Impact factor: 3.996

Review 3.  Association between circadian rhythms and neurodegenerative diseases.

Authors:  Yue Leng; Erik S Musiek; Kun Hu; Francesco P Cappuccio; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2019-02-12       Impact factor: 44.182

4.  Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Authors:  Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

5.  CLOCK rs1801260 Polymorphism is Associated with Susceptibility to Parkinson's Disease in a Chinese Population.

Authors:  Fan Lou; Ming Li; Yan Ren; Xiao-Guang Luo; Na Liu; Xiaohong Li
Journal:  Neurosci Bull       Date:  2017-08-05       Impact factor: 5.203

Review 6.  The aging clock: circadian rhythms and later life.

Authors:  Suzanne Hood; Shimon Amir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 7.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 8.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

9.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05

Review 10.  The role of CHMP2BIntron5 in autophagy and frontotemporal dementia.

Authors:  Christopher S Krasniak; S Tariq Ahmad
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.